46 reports

TABLE ## ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)

  • Gene Therapy
  • World
  • Europe
  • North America
  • APAC
  • Cancer Incidence
  • Pharmaceutical R&D Expenditure

Report Scope: This research report presents an in-depth analysis of the global cell therapy biomanufacturing market by product type, application and region.The report discusses the key inhibitors to the growth of cell therapy biomanufacturing. The report discusses the role of participants in the supply chain from...

  • Cell Therapy
  • World
  • APAC
  • Stem Cell Transplantation

Figure ##. Allogeneic: Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

  • Cell Therapy
  • North America
  • Diabetes Incidence
  • Stem Cell Transplantation

Figure ##. Allogeneic: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

  • Cell Therapy
  • APAC
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

Figure ##. Allogeneic: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

  • Cell Therapy
  • Europe
  • United Kingdom
  • France
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

## ALLOGENEIC STEM CELL THERAPY

  • Cell Therapy
  • APAC
  • North America
  • Europe
  • Health Expenditure
  • Musculoskeletal Disorders Prevalence

The stem cell market was valued at USD 14.7 billion in 2020, and it is expected to reach approximately USD 26.40 billion in 2026, registering a CAGR of nearly 10.24% during the forecast period, 2021-2026. The growth of the market is attributed to the rising number of clinical trials and the growing adoption of stem cell therapies globally....

  • Cell Therapy
  • Healthcare
  • APAC
  • Europe
  • Health Expenditure
  • Cancer Incidence

Major players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, and Gamida Cell. The global stem cell therapy market is expected to grow from $8.62 billion in 2020 to $10.2 billion in 2021 at a compound annual growth...

  • Cell Therapy
  • United States
  • World
  • APAC
  • Chronic Disease Prevalence
  • Labour Utilisation

The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space.While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater...

  • Gene Therapy

Figure ##. Allogeneic: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

  • Cell Therapy
  • World
  • APAC
  • North America
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

TABLE ## STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY REGION, 2019–2026 (USD MILLION)

  • Cell Therapy
  • Europe
  • APAC
  • North America
  • Cancer Incidence
  • Chronic Disease Prevalence

"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market Opportunity: More Than USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Global Cell Therapy Clinical Pipeline: 1000 Cell Therapies •...

  • Cell Therapy
  • World

"Global Cell Therapy Market Outlook, Patent & Clinical Trials Insight 2028" Report Highlights: • Global Cell Therapy Market Opportunity: > USD 45 Billion By 2028 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Insight On More than 1600 Cell Therapies in Clinical Trials • Clinical...

  • Cell Therapy
  • World
  • Health Expenditure

TABLE ## EXAMPLES OF COMMERCIALIZED ALLOGENEIC CELL THERAPIES

  • Regenerative Medicine
  • United States
  • Europe
  • APAC
  • North America
  • Chronic Disease Prevalence
  • Health Expenditure

Cell Therapy Processing Market by Offering Type (Products, Services, and Software), and Application (Cardiovascular Devices, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026 The global cell therapy processing market was valued...

  • Cell Therapy
  • World
  • APAC
  • Europe

KEY FINDINGS The global stem cell market is evaluated to grow with a CAGR of 7.82%, during the forecast period of 2021 to 2028. Primary factors driving the market growth include the rising demand for stem cells in regenerative medicine, growing awareness about umbilical cord stem cells, surging research and development...

  • Cell Therapy
  • APAC
  • World

INTRODUCTION Over the last few years, numerous biologics and small molecule drugs have made their way to the market. Most of these biologic products are not stable as liquid formulations, and tend to lose efficacy with alterations in their pharmacokinetic and pharmacodynamic properties, thereby, making it difficult to preserve...

  • Injectable Delivery
  • World
  • APAC
  • Europe
  • North America
  • Latin America
  • Container Traffic Volume
  • Biologics Approval

Global Allogeneic Stem Cells Market: About this market This allogeneic stem cells market analysis considers sales from regenerative therapy and drug discovery and development applications. Our study also finds the sales of allogeneic stem cells in Asia, Europe, North America, and ROW. In 2019, the regenerative therapy...

  • Regenerative Medicine
  • World
  • Europe
  • United States

Major players in the cell therapy market are Fibrocell Science Inc., JCR Pharmaceuticals Co. Ltd., PHARMICELL Co. Ltd., Osiris Therapeutics Inc., MEDIPOST, Vericel Corporation, Anterogen Co. Ltd., Kolon TissueGene Inc., Stemedica Cell Technologies Inc. and AlloCure. The global cell therapy market is expected to grow from $7.2 billion...

  • Cell Therapy
  • World
  • United States
  • Chronic Disease Prevalence

Major players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, ReNeuron Group, Takeda Pharmaceuticals, Magellan, Kolon...

  • Cell Therapy
  • World
  • United States
  • Chronic Disease Prevalence
  • Labour Utilisation

Major players in the cell therapy market are Fibrocell Science Inc., JCR Pharmaceuticals Co. Ltd., PHARMICELL Co. Ltd., Osiris Therapeutics Inc., MEDIPOST, Vericel Corporation, Anterogen Co. Ltd., Kolon TissueGene Inc., Stemedica Cell Technologies Inc., and AlloCure. The global cell therapy market is expected to grow from $7.2 billion...

  • Cell Therapy
  • World
  • United States
  • Chronic Disease Prevalence

Stem Cell Therapy Global Market Report 2020-30: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global stem cell therapy market. This report focuses on stem cell therapy market which is experiencing strong growth. The report gives a guide to the...

  • Cell Therapy
  • World

This study explores the global immuno-oncology (I-O) market’s evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune system is the...

  • Infectious Disease
  • Targeted Therapy
  • Cancer Immunotherapy
  • Pharmaceutical
  • Gene Therapy
  • Monoclonal Antibody
  • Cell Therapy
  • World

Figure ##. Allogeneic: Stem Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)

  • Cell Therapy
  • APAC
  • World
  • North America
  • Health Expenditure
  • Final Consumption Expenditures

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. Global Stem Cell Therapy Market By Type (Allogeneic, Autologous, Syngeneic), By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord...

  • Cell Therapy
  • World

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. This analysis indicates that the global regenerative medicine market was worth $35 billion...

  • Regenerative Medicine
  • World

"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell...

  • Cell Therapy
  • World

INTRODUCTION Advances in the fields of cell biology and regenerative medicine have led to the development of a variety of stem cell-based therapies for many cardiovascular, oncological, metabolic and musculoskeletal disorders. Driven by the revenues generated from stem cell therapies, the regenerative medicine market is...

  • Cell Therapy
  • World
  • North America
  • APAC
  • Europe

Complete iPSC Industry Report – Executive Summary Since the discovery of induced pluripotent stem cells (iPSCs) a large and thriving research products market has grown into existence, largely because the cells are non-controversial and can be generated directly from adult cells. It is clear that iPSCs represent a lucrative...

  • Cell Therapy
  • World
  • Japan
  • Europe
  • Meat Production

KEY FINDINGS The Europe stem cell market is predicted to register a CAGR of 8.03%, over the forecast period of 2021 to 2028. The region’s market growth is fueled by factors such as, significant investments across areas like medical research and healthcare facilities, the growing medical tourism, and the increased prevalence...

  • Clinical Trial
  • Pharmaceutical
  • Healthcare
  • Health Services
  • Cell Therapy
  • Medical Tourism
  • Belgium
  • Russia
  • Europe